However, both aberrant SOX9 expression in carcinoma tissues and elevated SOX9 expression are correlated to disease progression and poor prognosis for hepatocellular carcinoma, gastric cancer and prostate cancer [33-35]. This evidence concerns the gene SOX9 and carcinoma.